| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
We help companies give their users control over their data. Personal data is disorganized, hard to spot, and stored across many systems. That makes offering data rights—like deleting your data—very hard for companies. By making it easy, we can put users everywhere in control over their personal data.
Software solutions that enable IT to deliver secure, flexible and centrally-managed endpoints without compromising on end user experience, security or performance. ThinScale deliver enterprise software solutions designed to add tangible benefits to rem...
Diffbot is a VC-backed startup with a mission to make the web machine readable and accessible to all. Backed by a legendary investment team, including the founder of Earthlink, the first investor in Google, and the CEO of Yahoo!, as well as top executives at Facebook and Twitter, Diffbot aims to apply cutting edge computer vision and natural language techniques to understanding every web page on the web. Diffbot is already analyzing a significant portion of the internet for many of the top consumer destination sites. Diffbot is located withing biking distance from Stanford, currently employs an elite team of machine learning hackers, and is scaling quickly.